U.S. COVID-19 Hospitalizations Rise; Updated Omicron Vaccines Approved
The U.S. has seen a rise in COVID symptoms since early July, with over 18,000 cases in the week ending Sept. 2. The CDC and FDA have approved updated vaccines targeting the Omicron XBB.1.5 variant, set to be available before the respiratory season. These vaccines should offer protection against circulating subvariants like Eris and Pirola, and are recommended for everyone 6 months and older.
Pfizer, Moderna, and Novavax have reported that their updated vaccines are effective against newer variants. The CDC's advisory panel has voted to recommend these updated vaccines for everyone in the U.S. 6 months and older. The German Standing Committee on Vaccination (STIKO) has also issued a recommendation for children under 6 years old. The updated vaccines are approved for people 12 years and older, and authorized for children ages 6 months through 11 years.
With the end of the COVID-19 public health emergency, the federal government is no longer providing free vaccines to all Americans. However, many will still have access at no cost through various programs.
The updated COVID-19 vaccines are expected to provide protection during this fall and winter, assuming no significantly different variant emerges. The CDC advises that everyone 6 months and older should get the updated vaccine to stay protected against the virus, along with the seasonal flu virus and respiratory syncytial virus (RSV) that circulate simultaneously during the respiratory season.
Read also:
- Is it advisable to utilize your personal health insurance in a publicly-funded medical facility?
- Dietary strategies for IBS elimination: Aims and execution methods
- Benefits, suitable dosage, and safety considerations for utilizing pumpkin seed oil in treating an overactive bladder
- Harmful Medical Remedies: A Misguided Approach to Healing
